Related Experiment Video
Updated: Oct 17, 2025

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
Published on: April 24, 2021
GluN2A-ERK-mTOR pathway confers a vulnerability to LPS-induced depressive-like behaviour
Ester Francija1, Iva Lukic1, Zorica Petrovic2
1Department of Molecular Biology and Endocrinology, "VINČA" Institute of Nuclear Sciences - National Institute of thе Republic of Serbia, University of Belgrade, Belgrade.
Abstract:
Inflammation plays a key role in the pathogenesis of the major depressive disorder. Namely, neuroinflammation can induce the production of neuroactive metabolites that interfere with N-methyl-D-aspartate receptors (NMDAR)-mediated glutamatergic neurotransmission and contribute to depressive-like behaviour. On the other hand, mammalian target of rapamycin (mTOR) activity with synaptogenic effects is the main mediator of antidepressant effects of several potent NMDAR antagonists. In this study, we investigated the specific role of GluN2A subunits of NMDAR on the activity of mTOR signaling and behaviour in lipopolysaccharide (LPS)-induces model of depression. The results showed that mice lacking GluN2A subunit did not display depressive-like behavior after the immune challenge, opposite to LPS-treated wild-type mice. Specifically, in GluN2A knockout mice, we estimated the activity of the mTOR pathway in the hippocampus and prefrontal cortex (PFC) by measuring synaptic levels of upstream regulators (p-Akt, p-ERK, and p-GSK3β) and downstream effectors (p-mTOR, and p-p70S6K) of mTOR activity. In addition, we assessed the changes in the levels of two important synaptic markers, GluA1 and PSD-95. Contrary to downregulated mTOR signaling and decreased synaptic markers in LPS-treated wild-type animals, the resilience of GluN2A KO mice to depressive-like behaviour was paralleled with sustained mTOR signaling activity synaptic stability in hippocampus and PFC. Finally, we disclosed that resistance of GluN2A knockouts to LPS-induced depressive-like behavior was ERK-dependent. These findings demonstrate that GluN2A-ERK-mTOR signaling is a vulnerability factor of inflammation-related depressive behaviour, making this signaling pathway the promising target for developing novel antidepressants.
Insights
Mice lacking the GluN2A subunit of N-methyl-D-aspartate receptors (NMDAR) resist depression-like behaviors induced by inflammation. This resilience is linked to sustained mTOR signaling, highlighting GluN2A-ERK-mTOR pathways as potential antidepressant targets.
Area of Science:
- Neuroscience
- Molecular Psychiatry
- Immunology
Background:
- Inflammation and neuroinflammation are implicated in major depressive disorder (MDD) pathogenesis.
- Neuroinflammation disrupts N-methyl-D-aspartate receptor (NMDAR)-mediated neurotransmission, contributing to depressive behaviors.
- Mammalian target of rapamycin (mTOR) signaling, with its synaptogenic effects, mediates antidepressant actions of NMDAR antagonists.
Purpose of the Study:
- To investigate the role of GluN2A subunits of NMDAR in modulating mTOR signaling and behavior within a lipopolysaccharide (LPS)-induced mouse model of depression.
- To elucidate the specific contribution of GluN2A to inflammation-induced depressive-like behaviors and associated molecular changes.
Main Methods:
- Utilized a lipopolysaccharide (LPS)-induced mouse model to mimic inflammation-related depression.
- Compared depressive-like behaviors and molecular signaling in wild-type (WT) mice and GluN2A knockout (KO) mice.
- Assessed mTOR pathway activity in the hippocampus and prefrontal cortex (PFC) by measuring levels of key signaling proteins (p-Akt, p-ERK, p-GSK3β, p-mTOR, p-p70S6K).
- Quantified synaptic markers, including GluA1 and PSD-95, to evaluate synaptic integrity.
Main Results:
- LPS administration induced depressive-like behaviors in WT mice but not in GluN2A KO mice.
- LPS-treated WT mice exhibited downregulated mTOR signaling and reduced synaptic markers (GluA1, PSD-95) in the hippocampus and PFC.
- GluN2A KO mice showed sustained mTOR signaling activity and synaptic stability, correlating with their resilience to depressive behaviors.
- The resistance of GluN2A KO mice to LPS-induced depression was found to be dependent on ERK signaling.
Conclusions:
- The GluN2A subunit of NMDAR is a critical factor in the vulnerability to inflammation-related depressive behaviors.
- The GluN2A-ERK-mTOR signaling pathway plays a significant role in the pathogenesis of depression induced by immune challenges.
- Targeting the GluN2A-ERK-mTOR pathway offers a promising strategy for the development of novel antidepressant therapies for inflammation-associated depression.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
cAMP-dependent Protein Kinase Pathways

